Kbc Group Nv Horizon Therapeutics Public LTD CO Transaction History

Kbc Group Nv

  • $33.1 Billion
  • Q2 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Feb 15, 2024
SELL
$98.98 - $115.74 $6.24 Million - $7.29 Million
-63,015 Reduced 75.19%
20,794 $2.41 Million
Q2 2023

Feb 15, 2024
SELL
$96.34 - $112.38 $27.7 Million - $32.3 Million
-287,317 Reduced 77.42%
83,809 $8.62 Million
Q2 2023

Jul 28, 2023
SELL
$96.34 - $112.38 $6.22 Million - $7.26 Million
-64,559 Reduced 43.51%
83,809 $8.62 Million
Q1 2023

Feb 14, 2024
SELL
$107.32 - $113.5 $15.7 Million - $16.6 Million
-146,104 Reduced 49.62%
148,368 $16.2 Million
Q1 2023

May 04, 2023
SELL
$107.32 - $113.5 $23.9 Million - $25.3 Million
-222,472 Reduced 59.99%
148,368 $16.2 Million
Q4 2022

Feb 14, 2024
SELL
$62.39 - $113.8 $4.06 Million - $7.41 Million
-65,100 Reduced 18.1%
294,472 $33.5 Million
Q3 2022

Feb 15, 2024
BUY
$58.92 - $84.67 $21.9 Million - $31.4 Million
371,126 New
371,126 $23 Million
Q3 2022

Nov 08, 2022
BUY
$58.92 - $84.67 $685,534 - $985,135
11,635 Added 3.24%
370,840 $23 Million
Q2 2022

Feb 14, 2024
SELL
$79.4 - $116.36 $2.03 Million - $2.98 Million
-25,594 Reduced 6.64%
359,572 $28.7 Million
Q2 2022

Jul 26, 2022
SELL
$79.4 - $116.36 $2.06 Million - $3.02 Million
-25,961 Reduced 6.74%
359,205 $28.7 Million
Q1 2022

Feb 14, 2024
BUY
$86.42 - $109.81 $9.7 Million - $12.3 Million
112,292 Added 41.15%
385,166 $40.5 Million
Q1 2022

May 06, 2022
BUY
$86.42 - $109.81 $9.7 Million - $12.3 Million
112,292 Added 41.15%
385,166 $40.5 Million
Q4 2021

Feb 14, 2024
BUY
$98.56 - $119.91 $26.9 Million - $32.7 Million
272,874 New
272,874 $29.4 Million
Q4 2021

Feb 03, 2022
SELL
$98.56 - $119.91 $1.03 Million - $1.25 Million
-10,431 Reduced 3.68%
272,874 $29.4 Million
Q3 2021

Nov 10, 2021
BUY
$91.91 - $110.37 $11.1 Million - $13.3 Million
120,309 Added 73.81%
283,305 $31 Million
Q2 2021

Aug 11, 2021
SELL
$86.24 - $95.92 $1.06 Million - $1.17 Million
-12,245 Reduced 6.99%
162,996 $15.3 Million
Q1 2021

Apr 26, 2021
BUY
$71.83 - $95.48 $5.59 Million - $7.43 Million
77,858 Added 79.95%
175,241 $16.1 Million
Q4 2020

Feb 10, 2021
BUY
$67.0 - $84.39 $3.65 Million - $4.59 Million
54,407 Added 126.6%
97,383 $7.12 Million
Q3 2020

Oct 28, 2020
BUY
$55.23 - $79.93 $2.37 Million - $3.44 Million
42,976 New
42,976 $3.34 Million

Others Institutions Holding HZNP

# of Institutions
39
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email